Insider · CIK 0001200155

GANDOLFO JOHN P

Reports to the SEC for 6 companies · ROCKAWAY, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001200155

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-09	ECORelectroCore, Inc.A Award	Director	AAward	+11.1K sh	—	—	99,221
2025-12-11	OGENORAGENICS INC · Non-Employee Director Option (Right to Buy)A Award	Director	AAward	+125K sh	—	—	125,000
2025-09-02	ECORelectroCore, Inc.A Award	Director	AAward	+19K sh	—	—	88,098
2025-05-23	ECORelectroCore, Inc.P Purchase	Director	PPurchase	+1,800 sh	$5.01	+$9,018	69,087
2024-09-19	OGENORAGENICS INC · Non-Employee Director Option (Right to Buy)A Award	Director	AAward	+45K sh	—	—	45,000
2024-09-03	ECORelectroCore, Inc.A Award	Director	AAward	+16.6K sh	—	—	67,287
2024-06-13	ECORelectroCore, Inc.P Purchase	Director	PPurchase	+1,000 sh	$6.43	+$6,430	50,704
2024-02-12	HYPDHYPERION DEFI, INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+60K sh	—	—	60,000
2024-01-10	ODYYOdyssey Health, Inc.A Award	Former Director	AAward	+1.5M sh	$0.09	+$135K	1,738,792
2024-01-10	ODYYOdyssey Health, Inc. · Restricted Stock Unit (Right to Buy)D Disposition to Issuer	Former Director	DDisposition to Issuer	−1.5M sh	$0.09	−$135K	0
2023-10-04	OGENORAGENICS INC · Non-Employee Director Option (Right to Buy)A Award	Director	AAward	+5,102 sh	—	—	5,102
2023-08-04	ECORelectroCore, Inc.A Award	Director	AAward	+21.7K sh	—	—	49,704
2023-05-31	HYPDHYPERION DEFI, INC.P Purchase	Chief Financial Officer	PPurchase	+2,000 sh	$2.79	+$5,580	8,000
2023-01-17	HYPDHYPERION DEFI, INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+68.2K sh	—	—	68,235
2023-01-12	ODYYOdyssey Health, Inc. · Restricted Stock Unit (Right to Buy)A Award	Former Director	AAward	+500K sh	$0.30	+$150K	1,500,000
2022-12-02	ECORelectroCore, Inc.A Award	Director	AAward	+206K sh	—	—	419,497
2022-05-19	ODYYOdyssey Health, Inc. · Stock Option (Right to Buy)A Award	Former Director	AAward	+250K sh	$0.30	+$75K	1,500,000
2022-05-19	ODYYOdyssey Health, Inc. · Stock Option (Right to Buy)A Award	Former Director	AAward	+250K sh	$0.30	+$75K	1,250,000
2022-05-17	ECORelectroCore, Inc.P Purchase	Director	PPurchase	+15K sh	$0.36	+$5,400	19,000
2022-02-14	HYPDHYPERION DEFI, INC. · Stock Options (right to buy)A Award	Chief Financial Officer	AAward	+23.2K sh	—	—	23,211
2021-09-14	ODYYOdyssey Health, Inc. · Restricted Stock Unit (Right to Buy)A Award	Former Director	AAward	+500K sh	$0.45	+$225K	1,000,000
2021-06-16	HYPDHYPERION DEFI, INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+128K sh	$6.01	+$771K	128,258
2021-06-11	ECORelectroCore, Inc. · Deferred Stock UnitsA Award	Director	AAward	+44.5K sh	—	—	44,510
2021-03-16	ECORelectroCore, Inc.P Purchase	Director	PPurchase	+4,000 sh	$2.15	+$8,600	4,000
2020-11-19	HYPDHYPERION DEFI, INC.P Purchase	Chief Financial Officer	PPurchase	+4,000 sh	$3.40	+$13.6K	6,000
2020-06-30	HYPDHYPERION DEFI, INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+115K sh	—	—	114,774
2020-04-02	ECORelectroCore, Inc. · Deferred Stock UnitsA Award	Director	AAward	+150K sh	—	—	150,000
2019-08-16	HYPDHYPERION DEFI, INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+53.4K sh	—	—	53,402
2018-07-24	HYPDHYPERION DEFI, INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+24.8K sh	—	—	24,842
2018-06-28	HYPDHYPERION DEFI, INC.P Purchase	Chief Financial Officer	PPurchase	+2,000 sh	$5.86	+$11.7K	2,000
2018-04-16	HYPDHYPERION DEFI, INC. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+71.2K sh	—	—	71,200
2014-09-04	XTNTXtant Medical Holdings, Inc. · Employee Stock OptionA Award	CFO	AAward	+30K sh	—	—	30,000
2013-05-24	XTNTXtant Medical Holdings, Inc. · Restricted Stock UnitA Award	CFO	AAward	+101K sh	—	—	100,500
2013-05-24	XTNTXtant Medical Holdings, Inc. · Employee Stock OptionA Award	CFO	AAward	+70K sh	—	—	70,000
2012-03-27	XTNTXtant Medical Holdings, Inc. · Employee Stock OptionA Award	CFO	AAward	+70K sh	—	—	70,000
2011-05-02	XTNTXtant Medical Holdings, Inc. · WarrantP Purchase	CFO	PPurchase	+3,977 sh	—	—	3,977
2011-05-02	XTNTXtant Medical Holdings, Inc.P Purchase	CFO	PPurchase	+9,943 sh	$3.52	+$35K	9,943
2005-12-20	BIOJECT MEDICAL TECHNOLOGIES INCCommon StockD Disposition to Issuer	CFO	DDisposition to Issuer	−11.3K sh	—	—	—
2004-12-20	BIOJECT MEDICAL TECHNOLOGIES INCCommon StockD Disposition to Issuer	CFO	DDisposition to Issuer	−11.3K sh	—	—	—
2003-12-20	BIOJECT MEDICAL TECHNOLOGIES INCCommon StockD Disposition to Issuer	CFO	DDisposition to Issuer	−11.3K sh	—	—	—
2002-12-20	BIOJECT MEDICAL TECHNOLOGIES INCOption to Purchase Common StockA Award	CFO	AAward	+11.3K sh	—	—	—
2002-12-20	BIOJECT MEDICAL TECHNOLOGIES INCOption to Purchase Common StockA Award	CFO	AAward	+11.3K sh	—	—	—
2002-12-20	BIOJECT MEDICAL TECHNOLOGIES INCOption to Purchase Common StockA Award	CFO	AAward	+11.3K sh	—	—	—
2002-10-15	BIOJECT MEDICAL TECHNOLOGIES INCOption to Purchase Common StockA Award	CFO	AAward	+16.7K sh	—	—	—
2002-10-15	BIOJECT MEDICAL TECHNOLOGIES INCOption to Purchase Common StockA Award	CFO	AAward	+16.7K sh	—	—	—
2002-10-15	BIOJECT MEDICAL TECHNOLOGIES INCOption to Purchase Common StockA Award	CFO	AAward	+16.7K sh	—	—	—

Recent filings

Accepted (ET)
Sep 104
GANDOLFO JOHN P0001493152-26-042145
SEC(opens sec.gov)
Dec 154
GANDOLFO JOHN P0001200155-25-000004
SEC(opens sec.gov)
Sep 44
GANDOLFO JOHN P0001493152-25-012633
SEC(opens sec.gov)
May 274
GANDOLFO JOHN P0001641172-25-012413
SEC(opens sec.gov)
Sep 204
GANDOLFO JOHN P0001493152-24-037729
SEC(opens sec.gov)
Sep 54
GANDOLFO JOHN P0001193805-24-001092
SEC(opens sec.gov)
Jun 174
GANDOLFO JOHN P0001193805-24-000813
SEC(opens sec.gov)
Feb 144
GANDOLFO JOHN P0001104659-24-023657
SEC(opens sec.gov)
Jan 164
GANDOLFO JOHN P0001683168-24-000304
SEC(opens sec.gov)
Oct 64
GANDOLFO JOHN P0001493152-23-036522
SEC(opens sec.gov)
Aug 84
GANDOLFO JOHN P0001193805-23-001122
SEC(opens sec.gov)
May 314
GANDOLFO JOHN P0001104659-23-066718
SEC(opens sec.gov)
Jan 184
GANDOLFO JOHN P0001415889-23-001053
SEC(opens sec.gov)
Jan 134
GANDOLFO JOHN P0001683168-23-000192
SEC(opens sec.gov)
Dec 64
GANDOLFO JOHN P0001193805-22-001657
SEC(opens sec.gov)
Jun 84
GANDOLFO JOHN P0001683168-22-004241
SEC(opens sec.gov)
May 184
GANDOLFO JOHN P0001193805-22-000826
SEC(opens sec.gov)
Feb 164
GANDOLFO JOHN P0001415889-22-001441
SEC(opens sec.gov)

Companies

Address

200 FORGE WAY, SUITE 205

ROCKAWAY, NJ, 07866